Aliskiren, either used alone or combined with standard medical therapies containing ACE inhibitor or ARB, is associated with more adverse events including hypotension, renal dysfunction, and hyperkalaemia in heart failure patients [6]. This evidence concerns the gene ACE and hypotensive disorder.